BRCA Tumor MASTR PlusBRCA HC MASTR PlusClarigo final


Multiplicom launches a new test for the diagnosis of chronic lymphocytic leukemia

Niel – Belgium, June 30th, 2015 – Multiplicom N.V. announces the release of a new gene panel, the CLL MASTR™ Plus kit, to improve the diagnosis of patients with chronic lymphocytic leukemia. This is the most common form of leukemia in adults and has a highly variable outcome. Multiplicom’s test helps to steer the treatment options to stabilize the disease.

Product launch BRCA Tumor MASTR™ Plus

Niel – Belgium, June 17th, 2015 – We are pleased to announce the release of the BRCA Tumor MASTR™ Plus molecular assay, research use only, for identification of SNVs in the coding region of BRCA1 and BRCA2 in various types of solid tumors.


5-9 Sep 27th European Congress of Pathology

Serbia I Belgrade

12-16 Oct BioJapan 2015

Japan I Yokohama

14-16 Oct European Meeting on Molecular Diagnostics

The Netherlands I Noordwijk aan Zee